EVENITY 105 mg pre-filled pen: dosing and use
Quick summary EVENITY 105 mg solution for injection in a pre-filled pen contains romosozumab and is used for osteoporosis in postmenopausal women at high risk of fracture. It is given as a subcutaneous injection,...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
EVENITY 105 mg solution for injection in a pre-filled pen contains romosozumab and is used for osteoporosis in postmenopausal women at high risk of fracture. It is given as a subcutaneous injection, usually as two injections once monthly for 12 months, with calcium and vitamin D often recommended during treatment.
Medical disclaimer:
This article is for general information only and does not replace the official patient leaflet, product information, or advice from a doctor or pharmacist. Treatment decisions, injection technique, and monitoring should always follow the prescribed plan for the individual patient.
What is EVENITY 105 mg solution for injection in a pre-filled pen?
EVENITY is a prescription medicine containing romosozumab. It is used in the treatment of osteoporosis in postmenopausal women at high risk of fracture.
It is described as having a dual effect on bone: it helps increase bone formation and also reduce bone resorption. This makes it different from medicines that only slow bone loss.
How is EVENITY given?
EVENITY is given by subcutaneous injection, meaning it is injected under the skin. The usual injection sites mentioned in the original content are the abdomen or thigh.
The treatment schedule described is two injections of 105 mg each once a month for 12 months. Patients should follow the exact schedule prescribed by their healthcare professional.
Injection technique and preparation should be checked carefully before use. The official instructions for the pre-filled pen should always be followed.
Key dosing points
| Topic | Information from the article |
|---|---|
| Dose | Two injections of 105 mg each |
| Frequency | Once monthly |
| Treatment length | 12 months |
| Supportive measures | Calcium and vitamin D supplementation is recommended during treatment |
| Monitoring | Serum calcium monitoring is important in patients at risk of hypocalcaemia |
What should patients know about injection sites?
The original content identifies the abdomen and thigh as the main injection sites. Rotating injection sites is advised to help reduce local irritation.
Good hygiene and careful preparation are important. The injection should be given according to the instructions supplied with the pen and the guidance of the healthcare team.
What side effects are mentioned?
The article highlights several possible side effects and risks. These include:
- Nasopharyngitis
- Injection-site reactions such as pain, swelling, or redness
- Hypocalcaemia
- Severe allergic reactions
- Cardiovascular issues
Patients should be monitored during treatment, and any concerning symptoms should be discussed with a healthcare professional promptly.
How does EVENITY compare with Prolia?
EVENITY and Prolia are both used in osteoporosis care, but they work differently. The original content describes Prolia (denosumab) as an anti-resorptive therapy that inhibits RANKL and reduces bone resorption.
EVENITY is described as having a dual action: it promotes bone formation and also reduces resorption. The article also notes a difference in dosing schedule, with Prolia given every six months and EVENITY given monthly for one year.
Choice of treatment depends on the individual patient and should be guided by the prescribing clinician.
What should be checked during treatment?
The original content notes that serum calcium levels may need monitoring, especially in patients at risk of hypocalcaemia. It also states that calcium and vitamin D supplementation is recommended during treatment.
After the 12-month course, the article says that a transition to an anti-resorptive therapy is often advised to help maintain treatment benefits. This should be planned by the treating clinician.
Frequently asked questions
▸ How is EVENITY administered?
EVENITY is given as a subcutaneous injection, usually into the abdomen or thigh, following the instructions for the pre-filled pen and the prescribed schedule.
▸ How often is EVENITY given?
The article states that it is given once monthly, with two 105 mg injections each month for 12 months.
▸ What are the common injection sites?
The abdomen and thigh are the injection sites mentioned in the original content. Rotating sites may help reduce irritation.
▸ Does EVENITY require monitoring?
The article highlights monitoring of serum calcium, especially in patients at risk of hypocalcaemia, and regular check-ups during treatment.
▸ What should happen after 12 months?
The original content says that an anti-resorptive therapy is often advised after the year-long course to help maintain benefits.
▸ Is EVENITY the same as Prolia?
No. The article describes them as different medicines with different mechanisms and dosing schedules.
Safety reminder
Do not change how this medicine is used without advice from the prescribing clinician. If there are questions about the injection technique, missed doses, side effects, calcium monitoring, or the official product leaflet, these should be reviewed with a doctor or pharmacist.
Related practical questions
How much do EVENITY injections cost?
The original content says the cost can vary depending on the provider, insurance coverage, and location. Patients should check local pricing and coverage details with the relevant healthcare or insurance service.
What are the disadvantages of EVENITY?
The article mentions the need for monthly injections, monitoring, and the possibility of side effects such as cardiovascular issues, allergic reactions, and hypocalcaemia.
How do you administer an EVENITY injection?
The original content says to wash hands, clean the injection site, follow the pen instructions carefully, and inject subcutaneously. The official instructions and professional training should always be followed.
For the most accurate and up-to-date information, always check the official product information supplied with the medicine and confirm any uncertainties with a healthcare professional.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.